Literature DB >> 1946439

In vivo protein-DNA interactions at the beta-globin gene locus.

T Ikuta1, Y W Kan.   

Abstract

We have investigated in vivo protein-DNA interactions in the beta-globin gene locus by dimethyl sulfate (DMS) footprinting in K562 cells, which express epsilon- and gamma-globin but not beta-globin. In the locus control region, hypersensitive site 2 (HS-2) exhibited footprints in several putative protein binding motifs. HS-3 was not footprinted. The beta promoter was also not footprinted, while extensive footprints were observed in the promoter of the active gamma-globin gene. No footprints were seen in the A gamma and beta 3' enhancers. With several motifs, additional protein interactions and alterations in binding patterns occurred with hemin induction. In HeLa cells, some footprints were observed in some of the motifs in HS-2, compatible with the finding that HS-2 has some enhancer function in HeLa cells, albeit much weaker than its activity in K562 cells. No footprint was seen in B lymphocytes. In vivo footprinting is a useful method for studying relevant protein-DNA interactions in erythroid cells.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1946439      PMCID: PMC52893          DOI: 10.1073/pnas.88.22.10188

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  30 in total

1.  Functional analysis and in vivo footprinting implicate the erythroid transcription factor GATA-1 as a positive regulator of its own promoter.

Authors:  S F Tsai; E Strauss; S H Orkin
Journal:  Genes Dev       Date:  1991-06       Impact factor: 11.361

2.  Human chronic myelogenous leukemia cell-line with positive Philadelphia chromosome.

Authors:  C B Lozzio; B B Lozzio
Journal:  Blood       Date:  1975-03       Impact factor: 22.113

3.  Fine structure genetic analysis of a beta-globin promoter.

Authors:  R M Myers; K Tilly; T Maniatis
Journal:  Science       Date:  1986-05-02       Impact factor: 47.728

4.  The "beta-like-globin" gene domain in human erythroid cells.

Authors:  D Tuan; W Solomon; Q Li; I M London
Journal:  Proc Natl Acad Sci U S A       Date:  1985-10       Impact factor: 11.205

5.  Genomic footprinting reveals cell type-specific DNA binding of ubiquitous factors.

Authors:  P B Becker; S Ruppert; G Schütz
Journal:  Cell       Date:  1987-11-06       Impact factor: 41.582

6.  In vivo protein-DNA interactions in a glucocorticoid response element require the presence of the hormone.

Authors:  P B Becker; B Gloss; W Schmid; U Strähle; G Schütz
Journal:  Nature       Date:  1986 Dec 18-31       Impact factor: 49.962

7.  Genomic sequencing.

Authors:  G M Church; W Gilbert
Journal:  Proc Natl Acad Sci U S A       Date:  1984-04       Impact factor: 11.205

8.  B lineage--specific interactions of an immunoglobulin enhancer with cellular factors in vivo.

Authors:  A Ephrussi; G M Church; S Tonegawa; W Gilbert
Journal:  Science       Date:  1985-01-11       Impact factor: 47.728

9.  Sequencing end-labeled DNA with base-specific chemical cleavages.

Authors:  A M Maxam; W Gilbert
Journal:  Methods Enzymol       Date:  1980       Impact factor: 1.600

10.  Embryonic erythroid differentiation in the human leukemic cell line K562.

Authors:  T Rutherford; J B Clegg; D R Higgs; R W Jones; J Thompson; D J Weatherall
Journal:  Proc Natl Acad Sci U S A       Date:  1981-01       Impact factor: 11.205

View more
  37 in total

1.  Nrf2 is essential for protection against acute pulmonary injury in mice.

Authors:  K Chan; Y W Kan
Journal:  Proc Natl Acad Sci U S A       Date:  1999-10-26       Impact factor: 11.205

2.  The role of trans-acting factors and DNA-bending in the silencing of human beta-globin gene expression.

Authors:  L R Drew; D C Tang; P E Berg; G P Rodgers
Journal:  Nucleic Acids Res       Date:  2000-07-15       Impact factor: 16.971

3.  Cooperative activities of hematopoietic regulators recruit RNA polymerase II to a tissue-specific chromatin domain.

Authors:  Kirby D Johnson; Jeffrey A Grass; Meghan E Boyer; Carol M Kiekhaefer; Gerd A Blobel; Mitchell J Weiss; Emery H Bresnick
Journal:  Proc Natl Acad Sci U S A       Date:  2002-08-22       Impact factor: 11.205

4.  Characterization of the factors binding to a PEPCK gene upstream hypersensitive site with LCR activity.

Authors:  T E Cheyette; T Ip; S Faber; Y Matsui; R Chalkley
Journal:  Nucleic Acids Res       Date:  1992-07-11       Impact factor: 16.971

5.  Functional erythroid promoters created by interaction of the transcription factor GATA-1 with CACCC and AP-1/NFE-2 elements.

Authors:  M Walters; D I Martin
Journal:  Proc Natl Acad Sci U S A       Date:  1992-11-01       Impact factor: 11.205

6.  The proinflammatory cytokine GM-CSF downregulates fetal hemoglobin expression by attenuating the cAMP-dependent pathway in sickle cell disease.

Authors:  Tohru Ikuta; Adekunle D Adekile; Diana R Gutsaeva; James B Parkerson; Shobha D Yerigenahally; Betsy Clair; Abdullah Kutlar; Nadine Odo; C Alvin Head
Journal:  Blood Cells Mol Dis       Date:  2011-09-25       Impact factor: 3.039

7.  In vivo protein-DNA interactions at hypersensitive site 3 of the human beta-globin locus control region.

Authors:  E C Strauss; S H Orkin
Journal:  Proc Natl Acad Sci U S A       Date:  1992-07-01       Impact factor: 11.205

Review 8.  Towards a comprehensive catalogue of validated and target-linked human enhancers.

Authors:  Molly Gasperini; Jacob M Tome; Jay Shendure
Journal:  Nat Rev Genet       Date:  2020-01-27       Impact factor: 53.242

9.  Dissection of the enhancer activity of beta-globin 5' DNase I-hypersensitive site 2 in transgenic mice.

Authors:  D Liu; J C Chang; P Moi; W Liu; Y W Kan; P T Curtin
Journal:  Proc Natl Acad Sci U S A       Date:  1992-05-01       Impact factor: 11.205

10.  Rhabdomyosarcoma arising in transgenic mice harboring the beta-globin locus control region fused with simian virus 40 large T antigen gene.

Authors:  T Teitz; J C Chang; M Kitamura; T S Yen; Y W Kan
Journal:  Proc Natl Acad Sci U S A       Date:  1993-04-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.